At what dose does venlafaxine start raising blood pressure?
Venlafaxine raises blood pressure primarily when it begins to inhibit the norepinephrine transporter (NET), which typically occurs at higher doses. A 2021 study directly measured NET inhibition in patients and found that venlafaxine only started blocking NET at a dose of 225 mg/day or more [3]. Below that dose, it acts mainly as a serotonin reuptake inhibitor and has little effect on blood pressure. This explains why blood pressure elevation is not seen in everyone taking venlafaxine—it depends on the dose reaching that threshold.
But venlafaxine can also lower blood pressure—how?
Despite its potential to raise blood pressure, venlafaxine also commonly causes orthostatic hypotension—a sudden drop in blood pressure when standing up. In a 2021 study of 429 older adults (60+ years) treated with venlafaxine, 20.1% of those without orthostatic hypotension at baseline developed it during treatment [5]. This effect was more common at higher doses (22.4% at ≥225 mg/day vs. 16.8% at lower doses) and was linked to a significantly higher risk of falls [5]. So while venlafaxine can push blood pressure up, it can also cause it to drop dangerously upon standing, especially in older patients.
What does this mean for someone taking venlafaxine?
The dual effect means that blood pressure monitoring is essential, especially at higher doses and in older adults. A 2025 study of patients undergoing electroconvulsive therapy found that those on venlafaxine were 5.46 times more likely to need antihypertensive medication after treatment, confirming that the drug can cause clinically significant blood pressure spikes in vulnerable individuals [4]. At the same time, the risk of orthostatic hypotension means that patients should be counseled about rising slowly from sitting or lying positions to prevent falls [5]. The bottom line: venlafaxine can raise or lower blood pressure, and the net effect depends on dose, age, and individual physiology—so regular blood pressure checks are a must.
Sources used in this answer
Combination Drug Therapy with Acetazolamide, Eszopiclone ± Venlafaxine for Obstructive Sleep Apnea (RESCUE-Combo): A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
In a trial of 20 OSA patients, adding venlafaxine to dual therapy did not clearly reduce OSA severity but improved some hypoxia measures; no serious blood pressure side effects were reported.
Orthostatic Hypotension, Hypertension Treatment, and Cardiovascular Disease
In a meta-analysis of 29,235 hypertension trial participants, intensive blood pressure treatment reduced cardiovascular risk regardless of orthostatic hypotension status.
Differential Potency of Venlafaxine, Paroxetine, and Atomoxetine to Inhibit Serotonin and Norepinephrine Reuptake in Patients With Major Depressive Disorder
In 32 depressed patients, venlafaxine started inhibiting norepinephrine reuptake only at 225 mg/day, which is the threshold for blood pressure elevation.
Venlafaxine During Electroconvulsive Therapy Is Associated With the Postictal Administration of Antihypertensive Medication
In 56 ECT patients, venlafaxine increased the odds of needing antihypertensive medication after treatment by 5.46 times (p=0.015).
Hypertension and orthostatic hypotension with venlafaxine treatment in depressed older adults.
In 429 older adults, 6.5% developed elevated blood pressure on venlafaxine (9.8% at ≥225 mg/day), and 20.1% developed orthostatic hypotension, increasing fall risk.